Sparta Pharmaceutical (SPTA) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks
Sparta Pharmaceutical (SPTA)

An SI Board Since September 1997

Posts	SubjectMarks	Bans	Symbol
22	1	0	SPTA

Emcee: Philip H. Lee	Type: Unmoderated

Introduction Market Data Compact

Corporate info on Sparta (3/4, unch) at spartapharma.com

Description of drug development pipeline at spartapharma.com

The Chairman of Sparta, William Sullivan, was former Chairman, President, and CEO of Burroughs Wellcome Company. Information on Burroughs Wellcome from Glaxo Wellcome website. See glaxowellcome.com

Jerry Hood, CEO, President, and Director, was former Head of Worldwide Development, SmithKline Beecham. From spartapharma.com

From 1997 Form 10K at edgar-online.com
"Furthermore, RTP and the Company may pursue a joint venture to evaluate and develop paclitaxel and related derivatives. If the terms of the joint venture are not agreed to by the end of 1997, RTP can license the rights to paclitaxel to another party."
-------

FDA applications for generic versions of paclitaxel [Taxol] are prohibited until 12/28/97, at the earliest (BioCentury, pg A1, 9/22/97). Some other suppliers of paclitaxel are listed at mypage.direct.ca under the heading "Companies."

Bristol Myers Squibb statement on Taxol at ww2.newswire.ca

Philip

Disclaimer: Invest at your own risk. Information taken from publicly available sources and is NOT guaranteed to be accurate. Information presented for discussion purposes only and not to be construed as investment advice. Do your own research. This article is neither a recommendation nor a offer to buy or sell any security whatsoever.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
22	The Math - (edited cuz I KNEW I had to be way off base...) From the Yahoo th	JEM	-	1/19/1999
21	SuperGen to Acquire Oncology Portfolio of Sparta Pharmaceuticals PR Newswire -	JEM	-	1/19/1999
20	Anyone still in this one? We should be due for another quarterly soon, shouldn	JEM	-	1/15/1999
19	$850,000 Awarded to Sparta Pharmaceuticals Inc. Business Wire - September 22,	JEM	-	9/22/1998
18	LOL!! JEM	JEM	-	5/29/1998
17	Boy! We WERE anxious to contribute SOMETHING to this thread, WEREN'T WE????	larry larsen	-	5/29/1998
16	right	Gabor	-	5/29/1998
15	NEWS!!!!!	Hal	-	5/29/1998
14	> I'd hate to be you guys. Then don't be! If a 1 - 5 reverse spli	larry larsen	-	5/11/1998
13	OUCH!!! 5-1 reverse split. I'd hate to be you guys.	Matthew Cooper	-	5/11/1998
12	FYI to anyone interested...Just spoke to Sparta's in-house shareholder cont	JEM	-	4/2/1998
11	SPTA News!! Sparta Pharmaceuticals Inc. Announces Clinical Findings at America	JEM	-	4/1/1998
10	Yes, I'm in at $1.90 but I have such a small no. of shares that I never bot	Mark Haythorn	-	3/2/1998
9	If you've been in for 2 years, you're in at a lot higher price, but I s	larry larsen	-	3/2/1998
8	Just to keep the thread alive- I've been in almost 2 yrs and have only see	Mark Haythorn	-	3/1/1998
7	Absolutely phenomenal activity in this near-dead puppy lately. Does anyone kno	larry larsen	-	2/21/1998
6	<<While SPTA may appear cheap on a cash per outstanding share basis, you	Andrew White	-	10/20/1997
5	Paul, While SPTA may appear cheap on a cash per outstanding share basis, you m	Philip H. Lee	-	10/19/1997
4	The patent along with cash value = 77 cents, book value = 80 cents. Anyway you	Paul Tran	-	10/19/1997
3	10/17 Sparta Pharmaceuticals Inc. Announces Patent Approval from the United	Andrew White	-	10/18/1997
2	Hi Phillip, Are you still watching SPTA? Heavy volume on Friday. Any ideas o	Steve Smith	-	10/11/1997
1	Other information on SPTA (3/4, unch): At June 30, 1997, the company had a cas	Philip H. Lee	-	9/30/1997

Go to reply# or date (mm/dd/yy):